Harmony Biosciences Holdings (HRMY) Return on Sales [ROS] (2020 - 2026)
Harmony Biosciences Holdings (HRMY) reported Return on Sales [ROS] of 34.18% for Q2 2026, up 10.15 percentage points from 24.03% a year earlier and up 16.87 percentage points from the prior quarter.
Harmony Biosciences Holdings (HRMY) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Harmony Biosciences Holdings' Return on Sales [ROS] came in at 24.03%, down 4.69 percentage points year-over-year; for FY2025, it came in at 24.00%, down 2.69 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of +13.37 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at 26.70% in FY2024 (-6.29 pp), 32.99% in FY2023 (+5.54 pp), 27.45% in FY2022 (-1.21 pp) and 28.66% in FY2021 (+18.02 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Sales [ROS] since Q3 2023.
- Year over year, Return on Sales [ROS] gained in three of the last eight quarters, with an average year-over-year change of -1.93 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q3 2023 (a gain of 30.10 percentage points); the low point was Q2 2024 (a drop of 22.59 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 17.31% (Q1 2026), 15.82% (Q4 2025) and 27.35% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Harmony Biosciences Holdings | 2.30 Bn | -452.73 Mn | 198.08 Mn | 34.18% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.18% |
| Mar 31, 2026 | 17.31% |
| Dec 31, 2025 | 15.82% |
| Sep 30, 2025 | 27.35% |
| Jun 30, 2025 | 24.03% |
| Mar 31, 2025 | 30.45% |
| Dec 31, 2024 | 27.69% |
| Sep 30, 2024 | 33.17% |
| Jun 30, 2024 | 12.36% |
| Mar 31, 2024 | 33.65% |
| Dec 31, 2023 | 23.87% |
| Sep 30, 2023 | 40.25% |
| Jun 30, 2023 | 34.95% |
| Mar 31, 2023 | 33.93% |
| Dec 31, 2022 | 37.11% |
| Sep 30, 2022 | 10.15% |
| Jun 30, 2022 | 30.94% |
| Mar 31, 2022 | 32.30% |
| Dec 31, 2021 | 31.39% |
| Sep 30, 2021 | 26.08% |
Harmony Biosciences Holdings Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();